You can buy or sell SBPH and other stocks, options, ETFs, and crypto commission-free!
Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. Read More The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.
52 Week High
52 Week Low
Simply Wall StMar 21
Imagine Owning Spring Bank Pharmaceuticals (NASDAQ:SBPH) And Wondering If The 30% Share Price Slide Is Justified
While it may not be enough for some shareholders, we think it is good to see the Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) share price up 12% in a single quarter. But that doesn’t change the fact that the returns over the last year have been less than pleasing. The cold reality is that the stock has dropped 30% in one year, under-performing the market. Check out our latest analysis for Spring Bank Pharmaceuticals Spring Bank Pharmaceuticals hasn’t yet reported any revenue yet, so it’s as much a busi...
Seeking AlphaMar 11
Spring Bank Pharmaceuticals (SBPH) CEO Martin Driscoll on Q4 2018 Results - Earnings Call Transcript
Spring Bank Pharmaceuticals (NASDAQ:SBPH) Q4 2018 Earnings Conference Call March 11, 2019 8:00 AM ET Company Participants Jon Freve - CFO Martin Driscoll - President &CEO Conference Call Participants Mari Cross - Jeffries Ted Tenthoff - Piper Jaffray Katherine Xu - William Blair Operator Good morning, ladies and gentlemen, and welcome to the Spring Bank March 11 2019 Conference Call. Currently, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instr...
-$0.57 per share
-$0.37 per share